- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07428603
Extrinsic Tooth Whitening Evaluation of a Whitening Toothpaste
February 19, 2026 updated by: Church & Dwight Company, Inc.
Six-Week Clinical Evaluation of a Toothpaste in Tooth Whitening Via Extrinsic Stain Removal
This randomized, examiner-blind, parallel-group clinical study evaluated the effectiveness of a whitening toothpaste compared with a control toothpaste in removing extrinsic tooth stain over six weeks of twice-daily unsupervised use.
Adult subjects were assessed at baseline and after 7, 14, 28, and 42 days of product use using the Macpherson Modification of the Lobene Stain Index.
Oral soft and hard tissues and subject-reported sensory responses were also evaluated throughout the study.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
This single-site, randomized, examiner-blind, two-cell parallel clinical trial enrolled adult subjects with qualifying extrinsic tooth stain.
Following baseline assessments, subjects were randomized to either a test whitening dentifrice or a marketed control dentifrice.
Subjects brushed twice daily for two minutes with their assigned toothpaste and toothbrush for 42 days.
Extrinsic stain on the labial surfaces of the 12 anterior teeth was evaluated at baseline and at Days 7, 14, 28, and 42 using the Macpherson Modification of the Lobene Stain Index, assessing stain intensity, stain area, and total stain scores.
Safety was monitored via oral soft and hard tissue examinations and subject-reported sensory assessments.
Treatment comparisons were performed using ANCOVA with baseline scores as covariates.
Study Type
Interventional
Enrollment (Actual)
118
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Indiana
-
Fort Wayne, Indiana, United States, 46825
- Salus Research, Inc.
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Adults 18-65 years in good general health
- Mean MLSI score ≥1.5 on labial surfaces of at least 8 of 12 anterior teeth
- Adequate oral hygiene and willingness to comply with study requirements
- Dental prophylaxis within past 18 months but not within past 3 months
- Willing to refrain from other whitening or oral care products during the study
Exclusion Criteria:
- Significant medical conditions or oral pathology affecting assessments
- History of adverse reactions to oral hygiene products
- Orthodontic appliances or restorations interfering with stain assessment
- Moderate or advanced periodontitis
- Recent bleaching or whitening treatments
- Pregnant or nursing
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Test Toothpaste
Investigational whitening toothpaste evaluated for removal of extrinsic tooth stain over 42 days of use.
|
Whitening toothpaste used twice daily for two minutes per brushing for six weeks.
|
|
Other: Sodium Fluoride Control Dentifrice
Non-whitening toothpaste used twice daily for two minutes per brushing for six weeks.
|
Non-whitening toothpaste used twice daily for two minutes per brushing for six weeks.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Extrinsic Tooth Stain (Total Stain Score)
Time Frame: Baseline to Day 42
|
Mean change in total extrinsic stain score measured on the labial surfaces of the 12 anterior teeth using the Macpherson Modification of the Lobene Stain Index, combining stain intensity and stain area scores.
|
Baseline to Day 42
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Stain Intensity and Stain Area Scores
Time Frame: Baseline to Days 7, 14, 28, and 42
|
Mean changes in stain intensity and stain area scores at each post-baseline time point.
|
Baseline to Days 7, 14, 28, and 42
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Subject-Reported Whitening and Sensory Assessments
Time Frame: Baseline and Days 7, 14, 28, and 42
|
Subject-reported perceptions of whitening, mouthfeel, and sensory responses collected via questionnaires.
|
Baseline and Days 7, 14, 28, and 42
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: Annahita Ghassemi, PhD, Church & Dwight, Inc.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
August 8, 2024
Primary Completion (Actual)
September 20, 2024
Study Completion (Actual)
September 20, 2024
Study Registration Dates
First Submitted
February 19, 2026
First Submitted That Met QC Criteria
February 19, 2026
First Posted (Actual)
February 24, 2026
Study Record Updates
Last Update Posted (Actual)
February 24, 2026
Last Update Submitted That Met QC Criteria
February 19, 2026
Last Verified
February 1, 2026
More Information
Terms related to this study
Other Study ID Numbers
- ST-24-U46
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
IPD Plan Description
The sponsor does not plan to share individual participant data.
Aggregate results are reported, but no de-identified datasets will be made publicly available.
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Stain Removal Efficacy
-
Mahidol UniversityCompletedStain Removal EfficacyThailand
-
Colgate PalmoliveCompleted
-
Heba HelalRecruiting
-
Boston Medical CenterSociety of Family PlanningTerminated
-
Cutera Inc.CompletedTattoo RemovalUnited States
-
Cutera Inc.Completed
-
FHI 360Ministry of Health, Chile; Chilean Institute of Reproductive MedicineCompleted
-
Cutera Inc.WithdrawnLaser Tattoo RemovalCanada
-
Universitat Internacional de CatalunyaCompleted
Clinical Trials on Whitening Test Dentifrice (Code 826)
-
Fujian Medical UniversityCompletedTooth DiscolorationChina
-
Pearl NetworkCompleted
-
Procter and GambleActive, not recruiting
-
HALEONCompletedA Clinical Study to Assess an Experimental Dentifrice in an Experimental Model of Early Stage CariesDental CariesUnited States
-
GlaxoSmithKlineCompleted
-
HALEONCompletedOral Hygiene | Dentin SensitivityUnited States
-
HALEONRecruitingGingivitis | Dental PlaqueUnited States
-
HALEONCompletedDentin SensitivityChina
-
BTS InternationalWest China HospitalCompleted
-
HALEONCompleted